Erratum: The Macrophage: The intersection between HIV infection and atherosclerosis (Journal of Leukocyte Biology (2010) 87, DOI: 10.1189/jlb.0809580);The macrophage: The intersection between HIV infection and atherosclerosis

Journal of Leukocyte Biology

Volumn 87, Issue 4, 2010, Pages 589-598

  Crowe, Suzanne M ^a,b,c   Westhorpe, Clare L V ^a   Mukhamedova, Nigora ^d   Jaworowski, Anthony ^a,c   Sviridov, Dmitri ^d   Bukrinsky, Michael ^e  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^e GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cholesterol; Coronary heart disease; Inflammation; Monocyte migration

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; CD16 ANTIGEN; COLONY STIMULATING FACTOR 1; INTERLEUKIN 18; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; VERY LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL ACTIVATION; CELL MIGRATION; CELL POPULATION; CHOLESTEROL METABOLISM; CORONARY ARTERY DISEASE; CORONARY RISK; CYTOKINE PRODUCTION; DYSLIPIDEMIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS LOAD;

EID: 77950559517     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0809580err     Document Type: Erratum

References (157)

1. Currier, J. S., Lundgren, J. D., Carr, A., Klein, D., Sabin, C. A., Sax, P. E., Schouten, J. T., Smieja, M. (2008) Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation 118, e29-e35.
2. Currier, J. S., Taylor, A., Boyd, F., Dezii, C. M., Kawabata, H., Burtcel, B., Maa, J. F., Hodder, S. (2003) Coronary heart disease in HIV-infected individuals. J. Acquir. Immune Defic. Syndr. 33, 506-512. (Pubitemid 36886080)
3. Klein, D., Hurley, L. B., Quesenberry, C. P., Jr., Sidney, S. (2002) Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J. Acquir. Immune Defic. Syndr. 30, 471-477.
4. Triant, V. A., Lee, H., Hadigan, C., Grinspoon, S. K. (2007) Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J. Clin. Endocrinol. Metab. 92, 2506-2512. (Pubitemid 47037350)
5. Triant, V. A., Meigs, J. B., Grinspoon, S. K. (2009) Association of C-reactive protein and HIV infection with acute myocardial infarction. J. Acquir. Immune Defic. Syndr. 51, 268-273.
6. Grunfeld, C., Delaney, J. A., Wanke, C., Currier, J. S., Scherzer, R., Biggs, M. L., Tien, P. C., Shlipak, M. G., Sidney, S., Polak, J. F., et al. (2009) Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. Aids.
7. Hsue, P. Y., Hunt, P. W., Schnell, A., Kalapus, S. C., Hoh, R., Ganz, P., Martin, J. N., Deeks, S. G. (2009) Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS 23, 1059-1067.
8. Lorenz, M. W., Stephan, C., Harmjanz, A., Staszewski, S., Buehler, A., Bickel, M., von Kegler, S., Ruhkamp, D., Steinmetz, H., Sitzer, M. (2008) Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis 196, 720-726.
9. Friis-Moller, N., Reiss, P., Sabin, C. A., Weber, R., Monforte, A., El-Sadr, W., Thiebaut, R., De Wit, S., Kirk, O., Fontas, E., et al. (2007) Class of antiretroviral drugs and the risk of myocardial infarction. N. Engl. J. Med. 356, 1723-1735. (Pubitemid 46658704)
10. Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365-1371. (Pubitemid 44924494)
11. Mujawar, Z., Rose, H., Morrow, M. P., Pushkarsky, T., Dubrovsky, L., Mukhamedova, N., Fu, Y., Dart, A., Orenstein, J. M., Bobryshev, Y. V., et al. (2006) Human Immunodeficiency Virus Impairs Reverse Cholesterol Transport from Macrophages. PLoS Biol. 4, e365. (Pubitemid 44760013)
12. Appay, V., Almeida, J. R., Sauce, D., Autran, B., Papagno, L. (2007) Accelerated immune senescence and HIV-1 infection. Exp. Gerontol. 42, 432-437. (Pubitemid 46561182)
13. Auffray, C., Sieweke, M. H., Geissmann, F. (2009) Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27, 669-692.
14. Belge, K. U., Dayyani, F., Horelt, A., Siedlar, M., Frankenberger, M., Frankenberger, B., Espevik, T., Ziegler-Heitbrock, L. (2002) The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J. Immunol. 168, 3536-3542.
15. Skinner, N. A., MacIsaac, C. M., Hamilton, J. A., Visvanathan, K. (2005) Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens. Clin. Exp. Immunol. 141, 270-278.
16. Ziegler-Heitbrock, L. (2007) The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J. Leukoc. Biol. 81, 584-592. (Pubitemid 46393535)
17. Barbolini, G., Scilabra, G. A., Botticelli, A., Botticelli, S. (1969) On the origin of foam cells in cholesterol-induced atherosclerosis of the rabbit. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 3, 24-32.
18. Gerrity, R. G., Naito, H. K. (1980) Ultrastructural identification of monocyte-derived foam cells in fatty streak lesions. Artery 8, 208-214. (Pubitemid 11154651)
19. Zucker-Franklin, D., Grusky, G., Marcus, A. (1978) Transformation of monocytes into "fat" cells. Lab. Invest. 38, 620-628.
20. Naif, H. M., Li, S., Alali, M., Sloane, A., Wu, L., Kelly, M., Lynch, G., Lloyd, A., Cunningham, A. L. (1998) CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J. Virol. 72, 830-836. (Pubitemid 28048908)
21. Rich, E. A., Chen, I. S., Zack, J. A., Leonard, M. L., O'Brien, W. A. (1992) Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J. Clin. Invest. 89, 176-183.
22. Sonza, S., Maerz, A., Deacon, N., Meanger, J., Mills, J., Crowe, S. (1996) Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J. Virol. 70, 3863-3869. (Pubitemid 26157366)
23. Kedzierska, K., Crowe, S. M. (2002) The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr. Med. Chem. 9, 1893-1903. (Pubitemid 35230257)
24. Zhu, T. (2002) HIV-1 in peripheral blood monocytes: an underrated viral source. J. Antimicrob. Chemother. 50, 309-311.
25. Lewin, S. R., Kirihara, J., Sonza, S., Irving, L., Mills, J., Crowe, S. M. (1998) HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals. AIDS 12, 719-727. (Pubitemid 28190694)
26. Orenstein, J. M., Fox, C., Wahl, S. M. (1997) Macrophages as a source of HIV during opportunistic infections. Science 276, 1857-1861. (Pubitemid 27443662)
27. Ellery, P. J., Tippett, E., Chiu, Y. L., Paukovics, G., Cameron, P. U., Solomon, A., Lewin, S. R., Gorry, P. R., Jaworowski, A., Greene, W. C., et al. (2007) The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J. Immunol. 178, 6581-6589. (Pubitemid 46717442)
28. Jaworowski, A., Kamwendo, D. D., Ellery, P., Sonza, S., Mwapasa, V., Tadesse, E., Molyneux, M. E., Rogerson, S. J., Meshnick, S. R., Crowe, S. M. (2007) CD16+ monocyte subset preferentially harbors HIV-1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV-1 infection. J. Infect. Dis. 196, 38-42. (Pubitemid 46982735)
29. Sung, T. L., Rice, A. P. (2009) miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog. 5, e1000263.
30. Wang, X., Ye, L., Hou, W., Zhou, Y., Wang, Y. J., Metzger, D. S., Ho, W. Z. (2009) Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 113, 671-674.
31. Peng, G., Greenwell-Wild, T., Nares, S., Jin, W., Lei, K. J., Rangel, Z. G., Munson, P. J., Wahl, S. M. (2007) Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 110, 393-400. (Pubitemid 47026861)
32. Sharova, N., Wu, Y., Zhu, X., Stranska, R., Kaushik, R., Sharkey, M., Stevenson, M. (2008) Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathog. 4, e1000057. (Pubitemid 351811537)
33. Galkina, E., Ley, K. (2009) Immune and inflammatory mechanisms of atherosclerosis (*). Annu. Rev. Immunol. 27, 165-197.
34. Libby, P., Ridker, P. M., Maseri, A. (2002) Inflammation and Atherosclerosis. Circulation 105, 1135-1143.
35. Cao, J. J., Arnold, A. M., Manolio, T. A., Polak, J. F., Psaty, B. M., Hirsch, C. H., Kuller, L. H., Cushman, M. (2007) Association of Carotid Artery Intima-Media Thickness, Plaques, and C-Reactive Protein With Future Cardiovascular Disease and All-Cause Mortality: The Cardiovascular Health Study. Circulation 116, 32-38.
36. Ridker, P. M., Danielson, E., Fonseca, F. A., Genest, J., Gotto, A. M., Jr., Kastelein, J. J., Koenig, W., Libby, P., Lorenzatti, A. J., Macfadyen, J. G., et al. (2009) Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 373, 1175-1182.
37. Libby, P. (2008) Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am. J. Med. 121, S21-S31.
38. Nakashima, Y., Raines, E. W., Plump, A. S., Breslow, J. L., Ross, R. (1998) Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 18, 842-851. (Pubitemid 28267666)
39. Murphy, A. J., Woollard, K. J., Hoang, A., Mukhamedova, N., Stirzaker, R. A., McCormick, S. P. A., Remaley, A. T., Sviridov, D., Chin-Dusting, J. (2008) High-Density Lipoprotein Reduces the Human Monocyte Inflammatory Response. Arterioscler. Thromb. Vasc. Biol. 28, 2071-2077.
40. Wu, H., Gower, R. M., Wang, H., Perrard, X.-Y. D., Ma, R., Bullard, D. C., Burns, A. R., Paul, A., Smith, C. W., Simon, S. I., et al. (2009) Functional Role of CD11c+ Monocytes in Atherogenesis Associated With Hypercholesterolemia. Circulation 119, 2708-2717.
41. Daugherty, A., Webb, N. R., Rateri, D. L., King, V. L. (2005) Thematic review series: The Immune System and Atherogenesis. Cytokine regulation of macrophage functions in atherogenesis. J. Lipid Res. 46, 1812-1822. (Pubitemid 41248477)
42. Thakore, A. H., Guo, C. Y., Larson, M. G., Corey, D., Wang, T. J., Vasan, R. S., D'Agostino, R. B., Sr., Lipinska, I., Keaney, J. F., Jr., Benjamin, E. J., et al. (2007) Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am. J. Cardiol. 99, 1598-1602. (Pubitemid 46773027)
43. Yudkin, J. S., Kumari, M., Humphries, S. E., Mohamed-Ali, V. (2000) Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148, 209-214. (Pubitemid 30064452)
44. Yoo, J. K., Kwon, H., Khil, L. Y., Zhang, L., Jun, H. S., Yoon, J. W. (2005) IL-18 induces monocyte chemotactic protein-1 production in macrophages through the phosphatidylinositol 3-kinase/Akt and MEK/ERK1/2 pathways. J. Immunol. 175, 8280-8286. (Pubitemid 41798393)
45. Rabkin, S. W. (2009) The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease. Nat. Clin. Pract. Cardiovasc. Med. 6, 192-199.
46. Ballou, S. P., Lozanski, G. (1992) Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 4, 361-368.
47. Singh, U., Devaraj, S., Dasu, M. R., Ciobanu, D., Reusch, J., Jialal, I. (2006) C-reactive protein decreases interleukin-10 secretion in activated human monocyte-derived macrophages via inhibition of cyclic AMP production. Arterioscler. Thromb. Vasc. Biol. 26, 2469-2475. (Pubitemid 44607467)
48. Devaraj, S., Davis, B., Simon, S. I., Jialal, I. (2006) CRP promotes monocyte-endothelial cell adhesion via Fcgamma receptors in human aortic endothelial cells under static and shear flow conditions. Am. J. Physiol. Heart Circ. Physiol. 291, H1170-H1176. (Pubitemid 44343660)
49. Pasceri, V., Cheng, J. S., Willerson, J. T., Yeh, E. T. (2001) Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103, 2531-2534. (Pubitemid 32521959)
50. Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., III, Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107, 499-511. (Pubitemid 36158056)
51. Devaraj, S., Singh, U., Jialal, I. (2009) The evolving role of C-reactive protein in atherothrombosis. Clin. Chem. 55, 229-238.
52. Hamirani, Y. S., Pandey, S., Rivera, J. J., Ndumele, C., Budoff, M. J., Blumenthal, R. S., Nasir, K. (2008) Markers of inflammation and coronary artery calcification: A systematic review. Atherosclerosis 201, 1-7.
53. Chomarat, P., Banchereau, J., Davoust, J., Palucka, A. K. (2000) IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 1, 510-514.
54. Elliott, P., Chambers, J. C., Zhang, W., Clarke, R., Hopewell, J. C., Peden, J. F., Erdmann, J., Braund, P., Engert, J. C., Bennett, D., et al. (2009) Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302, 37-48.
55. Harbord, R. M., Lawlor, D. A., Smith, G. D. (2009) Genetically elevated C-reactive protein and vascular disease. N. Engl. J. Med. 360, 933.
56. Eisenhardt, S. U., Habersberger, J., Murphy, A., Chen, Y. C., Woollard, K. J., Bassler, N., Qian, H., von Zur Muhlen, C., Hagemeyer, C. E., Ahrens, I., et al. (2009) Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circ. Res. 105, 128-137.
57. Kedzierska, K., Crowe, S. M. (2001) Cytokines and HIV-1: interactions and clinical implications. Antivir. Chem. Chemother. 12, 133-150. (Pubitemid 32963913)
58. Lafeuillade, A., Poizot-Martin, I., Quilichini, R., Gastaut, J. A., Kaplanski, S., Farnarier, C., Mege, J. L., Bongrand, P. (1991) Increased interleukin-6 production is associated with disease progression in HIV infection. AIDS 5, 1139-1140.
59. Weiss, L., Haeffner-Cavaillon, N., Laude, M., Gilquin, J., Kazatchkine, M. D. (1989) HIV infection is associated with the spontaneous production of interleukin-1 (IL-1) in vivo and with an abnormal release of IL-1 alpha in vitro. AIDS 3, 695-699. (Pubitemid 20021428)
60. Ostrowski, S. R., Katzenstein, T. L., Pedersen, B. K., Gerstoft, J., Ullum, H. (2008) Residual viraemia in HIV-1-infected patients with plasma viral load
61. Almeida, M., Cordero, M., Almeida, J., Orfao, A. (2007) Abnormal cytokine production by circulating monocytes and dendritic cells of myeloid origin in ART-treated HIV-1+ patients relates to CD4+ T-cell recovery and HCV co-infection. Curr. HIV Res. 5, 325-336. (Pubitemid 46785068)
62. Tilton, J. C., Johnson, A. J., Luskin, M. R., Manion, M. M., Yang, J., Adelsberger, J. W., Lempicki, R. A., Hallahan, C. W., McLaughlin, M., Mican, J. M., et al. (2006) Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons. J. Virol. 80, 11486-11497. (Pubitemid 44788864)
63. Barqasho, B., Nowak, P., Tjernlund, A., Kinloch, S., Goh, L. E., Lampe, F., Fisher, M., Andersson, J., Sonnerborg, A. (2009) Kinetics of plasma cytokines and chemokines during primary HIV-1 infection and after analytical treatment interruption. HIV Med. 10, 94-102.
64. Birx, D. L., Redfield, R. R., Tencer, K., Fowler, A., Burke, D. S., Tosato, G. (1990) Induction of interleukin-6 during human immunodeficiency virus infection. Blood 76, 2303-2310.
65. Breen, E. C., Rezai, A. R., Nakajima, K., Beall, G. N., Mitsuyasu, R. T., Hirano, T., Kishimoto, T., Martinez-Maza, O. (1990) Infection with HIV is associated with elevated IL-6 levels and production. J. Immunol. 144, 480-484. (Pubitemid 20036072)
66. Stone, S. F., Price, P., Keane, N. M., Murray, R. J., French, M. A. (2002) Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART. HIV Med. 3, 21-27. (Pubitemid 34189592)
67. Tebas, P., Henry, W. K., Matining, R., Weng-Cherng, D., Schmitz, J., Valdez, H., Jahed, N., Myers, L., Powderly, W. G., Katzenstein, D. (2008) Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk. PLoS One 3, e2021. (Pubitemid 352015919)
68. Kuller, L. H., Tracy, R., Belloso, W., De Wit, S., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 5, e203.
69. Lundgren, J. D., Neuhaus, J., Babiker, A., Cooper, D., Duprez, D., El-Sadr, W., Emery, S., Gordin, F., Kowalksa, J., Phillips, A., et al. (2008) Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients. AIDS 22, F17-F24.
70. Iannello, A., Samarani, S., Debbeche, O., Ahmad, R., Boulassel, M. R., Tremblay, C., Toma, E., Routy, J. P., Ahmad, A. (2009) Potential role of interleukin-18 in the immunopathogenesis of AIDS: involvement in fratricidal killing of NK cells. J. Virol. 83, 5999-6010.
71. Torre, D., Pugliese, A. (2006) Interleukin-18: a proinflammatory cytokine in HIV-1 infection. Curr. HIV Res. 4, 423-430. (Pubitemid 44524443)
72. Yearley, J. H., Xia, D., Pearson, C. B., Carville, A., Shannon, R. P., Mansfield, K. G. (2009) Interleukin-18 predicts atherosclerosis progression in SIV-infected and uninfected rhesus monkeys (Macaca mulatta) on a high-fat/high-cholesterol diet. Lab. Invest. 89, 657-667.
73. De Lorenzo, F., Boffito, M., Collot-Teixeira, S., Gazzard, B., McGregor, J. L., Shotliff, K., Xiao, H. (2009) Prevention of atherosclerosis in patients living with HIV. Vasc. Health Risk Manag. 5, 287-300.
74. De Lorenzo, F., Collot-Teixeira, S., Boffito, M., Feher, M., Gazzard, B., McGregor, J. L. (2008) Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measures. Curr. Med. Chem. 15, 2991-2999.
75. Reingold, J., Wanke, C., Kotler, D., Lewis, C., Tracy, R., Heymsfield, S., Tien, P., Bacchetti, P., Scherzer, R., Grunfeld, C., et al. (2008) Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study. J. Acquir. Immune Defic. Syndr. 48, 142-148.
76. Chaudhary, M., Kashyap, B., Gautam, H., Saini, S., Bhalla, P. (2008) Role of C-reactive protein in HIV infection: a pilot study. Viral Immunol. 21, 263-266. (Pubitemid 351873362)
77. Lau, B., Sharrett, A. R., Kingsley, L. A., Post, W., Palella, F. J., Visscher, B., Gange, S. J. (2006) C-reactive protein is a marker for human immunodeficiency virus disease progression. Arch. Intern. Med. 166, 64-70. (Pubitemid 43063843)
78. Wolf, K., Tsakiris, D. A., Weber, R., Erb, P., Battegay, M. (2002) Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1. J. Infect. Dis. 185, 456-462. (Pubitemid 34142807)
79. Ancuta, P., Kamat, A., Kunstman, K. J., Kim, E. Y., Autissier, P., Wurcel, A., Zaman, T., Stone, D., Mefford, M., Morgello, S., et al. (2008) Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 3, e2516.
80. Nockher, W. A., Bergmann, L., Scherberich, J. E. (1994) Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin. Exp. Immunol. 98, 369-374. (Pubitemid 24374718)
81. Sandanger, O., Ryan, L., Bohnhorst, J., Iversen, A. C., Husebye, H., Halaas, O., Landro, L., Aukrust, P., Froland, S. S., Elson, G., et al. (2009) IL-10 enhances MD-2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patients. J. Immunol. 182, 588-595.
82. Lien, E., Aukrust, P., Sundan, A., Muller, F., Froland, S. S., Espevik, T. (1998) Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events. Blood 92, 2084-2092. (Pubitemid 28446698)
83. Redd, A. D., Dabitao, D., Bream, J. H., Charvat, B., Laeyendecker, O., Kiwanuka, N., Lutalo, T., Kigozi, G., Tobian, A. A., Gamiel, J., et al. (2009) Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa. Proc. Natl. Acad. Sci. USA 106, 6718-6723.
84. Papasavvas, E., Pistilli, M., Reynolds, G., Bucki, R., Azzoni, L., Chehimi, J., Janmey, P. A., DiNubile, M. J., Ondercin, J., Kostman, J. R., et al. (2009) Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients. AIDS 23, 369-375.
85. Smith, B. J., Lightfoot, S. A., Lerner, M. R., Denson, K. D., Morgan, D. L., Hanas, J. S., Bronze, M. S., Postier, R. G., Brackett, D. J. (2009) Induction of cardiovascular pathology in a novel model of low-grade chronic inflammation. Cardiovasc. Pathol. 18, 1-10.
86. Schulbin, H., Bode, H., Stocker, H., Schmidt, W., Zippel, T., Loddenkemper, C., Engelmann, E., Epple, H. J., Arasteh, K., Zeitz, M., et al. (2008) Cytokine expression in the colonic mucosa of human immunodeficiency virus-infected individuals before and during 9 months of antiretroviral therapy. Antimicrob. Agents Chemother. 52, 3377-3384.
87. Passlick, B., Flieger, D., Ziegler-Heitbrock, H. W. (1989) Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74, 2527-2534. (Pubitemid 19286475)
88. Heine, G. H., Ulrich, C., Seibert, E., Seiler, S., Marell, J., Reichart, B., Krause, M., Schlitt, A., Kohler, H., Girndt, M. (2008) CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int. 73, 622-629. (Pubitemid 351264115)
89. Tacke, F., Alvarez, D., Kaplan, T. J., Jakubzick, C., Spanbroek, R., Llodra, J., Garin, A., Liu, J., Mack, M., van Rooijen, N., et al. (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117, 185-194. (Pubitemid 46048465)
90. Almeida, C. A., Price, P., French, M. A. (2002) Immune activation in patients infected with HIV type 1 and maintaining suppression of viral replication by highly active antiretroviral therapy. AIDS Res. Hum. Retroviruses 18, 1351-1355. (Pubitemid 36044739)
91. Gascon, R. L., Narvaez, A. B., Zhang, R., Kahn, J. O., Hecht, F. M., Herndier, B. G., McGrath, M. S. (2002) Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion. J. Acquir. Immune Defic. Syndr. 30, 146-153. (Pubitemid 34664410)
92. Pulliam, L., Gascon, R., Stubblebine, M., McGuire, D., McGrath, M. S. (1997) Unique monocyte subset in patients with AIDS dementia. Lancet 349, 692-695. (Pubitemid 27107748)
93. Trial, J., Rubio, J. A., Birdsall, H. H., Rodriguez-Barradas, M., Rossen, R. D. (2004) Monocyte activation by circulating fibronectin fragments in HIV-1-infected patients. J. Immunol. 173, 2190-2198. (Pubitemid 38976552)
94. Locher, C., Vanham, G., Kestens, L., Kruger, M., Ceuppens, J. L., Vingerhoets, J., Gigase, P. (1994) Expression patterns of Fc gamma receptors, HLA-DR and selected adhesion molecules on monocytes from normal and HIV-infected individuals. Clin. Exp. Immunol. 98, 115-122. (Pubitemid 24315461)
95. Thieblemont, N., Weiss, L., Sadeghi, H. M., Estcourt, C., Haeffner-Cavaillon, N. (1995) CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur. J. Immunol. 25, 3418-3424. (Pubitemid 26004949)
96. Jaworowski, A., Ellery, P., Maslin, C. L., Naim, E., Heinlein, A. C., Ryan, C. E., Paukovics, G., Hocking, J., Sonza, S., Crowe, S. M. (2006) Normal CD16 expression and phagocytosis of Mycobacterium avium complex by monocytes from a current cohort of HIV-1-infected patients. J. Infect. Dis. 193, 693-697. (Pubitemid 43273494)
97. An, G., Wang, H., Tang, R., Yago, T., McDaniel, J. M., McGee, S., Huo, Y., Xia, L. (2008) P-selectin glycoprotein ligand-1 is highly expressed on Ly-6Chi monocytes and a major determinant for Ly-6Chi monocyte recruitment to sites of atherosclerosis in mice. Circulation 117, 3227-3237.
98. Cybulsky, M. I., Iiyama, K., Li, H., Zhu, S., Chen, M., Iiyama, M., Davis, V., Gutierrez-Ramos, J. C., Connelly, P. W., Milstone, D. S. (2001) A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 107, 1255-1262. (Pubitemid 32494542)
99. Pluskota, E., Woody, N. M., Szpak, D., Ballantyne, C. M., Soloviev, D. A., Simon, D. I., Plow, E. F. (2008) Expression, activation and function of integrin {alpha}M{beta}2 (Mac-1) on neutrophil-derived microparticles. Blood 112, 2327-2335.
100. Muller, W. A., Weigl, S. A. (1992) Monocyte-selective transendothelial migration: dissection of the binding and transmigration phases by an in vitro assay. J. Exp. Med. 176, 819-828.
101. Schenkel, A. R., Mamdouh, Z., Muller, W. A. (2004) Locomotion of monocytes on endothelium is a critical step during extravasation. Nat. Immunol. 5, 393-400. (Pubitemid 38500088)
102. Weber, C., Zernecke, A., Libby, P. (2008) The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat. Rev. Immunol. 8, 802-815.
103. Boring, L., Gosling, J., Cleary, M., Charo, I. F. (1998) Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894-897. (Pubitemid 28410911)
104. Lesnik, P., Haskell, C. A., Charo, I. F. (2003) Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J. Clin. Invest. 111, 333-340. (Pubitemid 36182209)
105. Landsman, L., Bar-On, L., Zernecke, A., Kim, K. W., Krauthgamer, R., Shagdarsuren, E., Lira, S. A., Weissman, I. L., Weber, C., Jung, S. (2009) CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 113, 963-972.
106. Combadiere, C., Potteaux, S., Rodero, M., Simon, T., Pezard, A., Esposito, B., Merval, R., Proudfoot, A., Tedgui, A., Mallat, Z. (2008) Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 117, 1649-1657. (Pubitemid 351482605)
107. Serbina, N. V., Pamer, E. G. (2006) Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 7, 311-317.
108. Saederup, N., Chan, L., Lira, S. A., Charo, I. F. (2008) Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis. Circulation 117, 1642-1648. (Pubitemid 351482604)
109. Auffray, C., Fogg, D., Garfa, M., Elain, G., Join-Lambert, O., Kayal, S., Sarnacki, S., Cumano, A., Lauvau, G., Geissmann, F. (2007) Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317, 666-670. (Pubitemid 47229966)
110. Rossen, R. D., Smith, C. W., Laughter, A. H., Noonan, C. A., Anderson, D. C., McShan, W. M., Hurvitz, M. Y., Orson, F. M. (1989) HIV-1-stimulated expression of CD11/CD18 integrins and ICAM-1: a possible mechanism for extravascular dissemination of HIV-1-infected cells. Trans. Assoc. Am. Physicians 102, 117-130.
111. Stent, G., Cameron, P. U., Crowe, S. M. (1994) Expression of CD11/CD18 and ICAM-1 on monocytes and lymphocytes of HIV-1-infected individuals. J. Leukoc. Biol. 56, 304-309. (Pubitemid 24295798)
112. Ross, A. C., Armentrout, R., O'Riordan, M. A., Storer, N., Rizk, N., Harrill, D., El Bejjani, D., McComsey, G. A. (2008) Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophy. J. Acquir. Immune Defic. Syndr. 49, 499-506.
113. Birdsall, H. H., Porter, W. J., Green, D. M., Rubio, J., Trial, J., Rossen, R. D. (2004) Impact of fibronectin fragments on the transendothelial migration of HIV-infected leukocytes and the development of subendothelial foci of infectious leukocytes. J. Immunol. 173, 2746-2754. (Pubitemid 39063136)
114. Gerrity, R. G. (1981) The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions. Am. J. Pathol. 103, 191-200. (Pubitemid 11112974)
115. Westhorpe, C. L., Zhou, J., Webster, N. L., Kalionis, B., Lewin, S. R., Jaworowski, A., Muller, W. A., Crowe, S. M. (2009) Effects of HIV-1 infection in vitro on transendothelial migration by monocytes and monocyte-derived macrophages. J. Leukoc. Biol. 85, 1027-1035.
116. Lusis, A. J. (2000) Atherosclerosis. Nature 407, 233-241.
117. Brown, M. S., Goldstein, J. L. (2009) Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL. J. Lipid Res. 50, S15-S27.
118. Moore, K. J., Freeman, M. W. (2006) Scavenger Receptors in Atherosclerosis: Beyond Lipid Uptake. Arterioscler. Thromb. Vasc. Biol. 26, 1702-1711.
119. Kunjathoor, V. V., Febbraio, M., Podrez, E. A., Moore, K. J., Andersson, L., Koehn, S., Rhee, J. S., Silverstein, R., Hoff, H. F., Freeman, M. W. (2002) Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 277, 49982-49988. (Pubitemid 36014449)
120. Buono, C., Anzinger, J. J., Amar, M., Kruth, H. S. (2009) Fluorescent pegylated nanoparticles demonstrate fluid-phase pinocytosis by macrophages in mouse atherosclerotic lesions. J. Clin. Invest. 119, 1373-1381.
121. Greaves, D. R., Gordon, S. (2009) The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges. J. Lipid Res. 50, S282-S286.
122. Tabas, I. (2002) Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J. Clin. Invest. 110, 905-911.
123. Fielding, C. J., Fielding, P. E. (2001) Cellular cholesterol efflux. Biochim. Biophys. Acta 1533, 175-189.
124. Llodra, J., Angeli, V., Liu, J., Trogan, E., Fisher, E. A., Randolph, G. J. (2004) Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl. Acad. Sci. USA 101, 11779-11784. (Pubitemid 39095371)
125. Qin, C., Nagao, T., Grosheva, I., Maxfield, F. R., Pierini, L. M. (2006) Elevated Plasma Membrane Cholesterol Content Alters Macrophage Signaling and Function. Arterioscler. Thromb. Vasc. Biol. 26, 372-378. (Pubitemid 43732202)
126. Park, Y. M., Febbraio, M., Silverstein, R. L. (2009) CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J. Clin. Invest. 119, 136-145.
127. Seimon, T., Tabas, I. (2009) Mechanisms and consequences of macrophage apoptosis in atherosclerosis. J. Lipid Res. 50, S382-S387.
128. Phinikaridou, A., Hallock, K. J., Qiao, Y., Hamilton, J. A. (2009) A robust rabbit model of human atherosclerosis and atherothrombosis. J. Lipid Res. 50, 787-797.
129. Boyle, J. J., Harrington, H. A., Piper, E., Elderfield, K., Stark, J., Landis, R. C., Haskard, D. O. (2009) Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am. J. Pathol. 174, 1097-1108.
130. Wilson, H. M., Barker, R. N., Erwig, L. P. (2009) Macrophages: promising targets for the treatment of atherosclerosis. Curr. Vasc. Pharmacol. 7, 234-243.
131. Sima, A. V., Stancu, C. S., Simionescu, M. (2009) Vascular endothelium in atherosclerosis. Cell Tissue Res. 335, 191-203.
132. Bensinger, S. J., Tontonoz, P. (2008) Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 454, 470-477.
133. Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., Tontonoz, P. (2003) Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9, 213-219. (Pubitemid 36227724)
134. Beutler, B. A. (2009) TLRs and innate immunity. Blood 113, 1399-1407.
135. Castrillo, A., Joseph, S. B., Vaidya, S. A., Haberland, M., Fogelman, A. M., Cheng, G., Tontonoz, P. (2003) Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol. Cell 12, 805-816. (Pubitemid 37352775)
136. Tobias, P. S., Curtiss, L. K. (2007) Toll-like receptors in atherosclerosis. Biochem. Soc. Trans. 35, 1453-1455.
137. Edfeldt, K., Swedenborg, J., Hansson, G. K., Yan, Z. Q. (2002) Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105, 1158-1161. (Pubitemid 34225814)
138. Xu, X. H., Shah, P. K., Faure, E., Equils, O., Thomas, L., Fishbein, M. C., Luthringer, D., Xu, X. P., Rajavashisth, T. B., Yano, J., et al. (2001) Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104, 3103-3108. (Pubitemid 34014065)
139. Chait, A., Han, C. Y., Oram, J. F., Heinecke, J. W. (2005) Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? J. Lipid Res. 46, 389-403.
140. Vaisar, T., Pennathur, S., Green, P. S., Gharib, S. A., Hoofnagle, A. N., Cheung, M. C., Byun, J., Vuletic, S., Kassim, S., Singh, P., et al. (2007) Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J. Clin. Invest. 117, 746-756. (Pubitemid 46348533)
141. El-Sadr, W. M., Grund, B., Neuhaus, J., Babiker, A., Cohen, C. J., Darbyshire, J., Emery, S., Lundgren, J. D., Phillips, A., Neaton, J. D. (2008) Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Ann. Intern. Med. 149, 289-299.
142. El-Sadr, W. M., Lundgren, J. D., Neaton, J. D., Gordin, F., Abrams, D., Arduino, R. C., Babiker, A., Burman, W., Clumeck, N., Cohen, C. J., et al. (2006) CD4+ count-guided interruption of antiretroviral treatment. N. Engl. J. Med. 355, 2283-2296. (Pubitemid 44837777)
143. Sabin, C. A., Worm, S. W., Weber, R., Reiss, P., El-Sadr, W., Dabis, F., De Wit, S., Law, M., D'Arminio Monforte, A., Friis-Moller, N., et al. (2008) Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet 371, 1417-1426.
144. Kapoor, J. R. (2009) Management of dyslipidemia associated with protease inhibitors. Am. J. Cardiol. 103, 292-293.
145. Liang, J. S., Distler, O., Cooper, D. A., Jamil, H., Deckelbaum, R. J., Ginsberg, H. N., Sturley, S. L. (2001) HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia. Nat. Med. 7, 1327-1331. (Pubitemid 34007937)
146. Petit, J. M., Duong, M., Florentin, E., Duvillard, L., Chavanet, P., Brun, J. M., Portier, H., Gambert, P., Verges, B. (2003) Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen: a stable isotope kinetic study. J. Lipid Res. 44, 1692-1697. (Pubitemid 37185880)
147. Tran, H., Robinson, S., Mikhailenko, I., Strickland, D. K. (2003) Modulation of the LDL receptor and LRP levels by HIV protease inhibitors. J. Lipid Res. 44, 1859-1869. (Pubitemid 37356658)
148. Lenhard, J. M., Furfine, E. S., Jain, R. G., Ittoop, O., Orband-Miller, L. A., Blanchard, S. G., Paulik, M. A., Weiel, J. E. (2000) HIV protease inhibitors block adipogenesis and increase lipolysis in vitro. Antiviral Res. 47, 121-129.
149. Lenhard, J. M., Croom, D. K., Weiel, J. E., Winegar, D. A. (2000) HIV protease inhibitors stimulate hepatic triglyceride synthesis. Arterioscler. Thromb. Vasc. Biol. 20, 2625-2629.
150. Phillips, A. N., Carr, A., Neuhaus, J., Visnegarwala, F., Prineas, R., Burman, W. J., Williams, I., Drummond, F., Duprez, D., Belloso, W. H., et al. (2008) Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial. Antivir. Ther. 13, 177-187. (Pubitemid 351535369)
151. Riddler, S. A., Smit, E., Cole, S. R., Li, R., Chmiel, J. S., Dobs, A., Palella, F., Visscher, B., Evans, R., Kingsley, L. A. (2003) Impact of HIV Infection and HAART on Serum Lipids in Men. JAMA 289, 2978-2982. (Pubitemid 37430100)
152. Shor-Posner, G., Basit, A., Lu, Y., Cabrejos, C., Chang, J., Fletcher, M., Mantero-Atienza, E., Baum, M. K. (1993) Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am. J. Med. 94, 515-519. (Pubitemid 23142967)
153. Falkenbach, A., Klauke, S., Althoff, P. H. (1990) Abnormalities in cholesterol metabolism cause peripheral neuropathy and dementia in AIDS-a hypothesis. Med. Hypotheses 33, 57-61. (Pubitemid 20286317)
154. El-Sadr, W. M., Mullin, C., Carr, A., Gibert, C., Rappoport, C., Visnegarwala, F., Grunfeld, C., Raghavan, S. (2005) Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort. HIV Med. 6, 114-121. (Pubitemid 40425975)
155. Rose, H., Hoy, J., Woolley, I., Tchoua, U., Bukrinsky, M., Dart, A., Sviridov, D. (2008) HIV infection and high density lipoprotein metabolism. Atherosclerosis 199, 79-86. (Pubitemid 351842701)
156. Bukrinsky, M., Sviridov, D. (2007) HIV and cardiovascular disease: contribution of HIV-infected macrophages to development of atherosclerosis. PLoS Med. 4, e43. (Pubitemid 46191841)
157. Micheletti, R. G., Fishbein, G. A., Fishbein, M. C., Singer, E. J., Weiss, R. E., Jeffries, R. A., Currier, J. S. (2009) Coronary atherosclerotic lesions in human immunodeficiency virus-infected patients: a histopathologic study. Cardiovasc. Pathol. 18, 28-36.